Correction: Oral Intake of Royal Jelly Has Protective Effects against Tyrosine Kinase Inhibitor-Induced Toxicity in Patients with Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled Trial. Medicines, 2019, 6, 2
We, the authors, wish to make the following correction to our published paper [...] View Full-Text
Araki, K.; Miyata, Y.; Ohba, K.; Nakamura, Y.; Matsuo, T.; Mochizuki, Y.; Sakai, H. Correction: Oral Intake of Royal Jelly Has Protective Effects against Tyrosine Kinase Inhibitor-Induced Toxicity in Patients with Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled Trial. Medicines, 2019, 6, 2. Medicines 2020, 7, 71. https://0-doi-org.brum.beds.ac.uk/10.3390/medicines7110071
Araki K, Miyata Y, Ohba K, Nakamura Y, Matsuo T, Mochizuki Y, Sakai H. Correction: Oral Intake of Royal Jelly Has Protective Effects against Tyrosine Kinase Inhibitor-Induced Toxicity in Patients with Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled Trial. Medicines, 2019, 6, 2. Medicines. 2020; 7(11):71. https://0-doi-org.brum.beds.ac.uk/10.3390/medicines7110071
Chicago/Turabian StyleAraki, Kyohei; Miyata, Yasuyoshi; Ohba, Kojiro; Nakamura, Yuichiro; Matsuo, Tomohiro; Mochizuki, Yasushi; Sakai, Hideki. 2020. "Correction: Oral Intake of Royal Jelly Has Protective Effects against Tyrosine Kinase Inhibitor-Induced Toxicity in Patients with Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled Trial. Medicines, 2019, 6, 2" Medicines 7, no. 11: 71. https://0-doi-org.brum.beds.ac.uk/10.3390/medicines7110071